NeuBase Therapeutics

NeuBase Therapeutics

closed

Accelerating the genetic revolution developing a new class of designer synthetic medicines.

HQ location
Pittsburgh, United States
Website
neubasetherapeutics.com
Launch date
–
Employees
11-50 people
Market cap
$1.3m
Enterprise value
$1m
Share price
$0.38 NBSE
Recent deals
https://twitter.com/neubaseinchttps://www.linkedin.com/company/neubase-therapeutics
    • Edit
loading funding rounds…
Greenlight Capital
Greenlight Capital(exited)

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD201720182019202020212022
Revenues000000000000000000000000
EBITDA000000000000000000000000
Profit000000000000000000000000
EV000000000000000000000000
EV / revenue00.0x00.0x00.0x00.0x00.0x00.0x
EV / EBITDA00.0x00.0x00.0x00.0x00.0x00.0x
R&D budget000000000000000000000000

Source: Company filings or news article

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by NeuBase Therapeutics

Edit
OHR Pharmaceutical
OHR Pharmaceutical
PNA Innovations
PNA Innovations
ACQUISITION by NeuBase Therapeutics Jan 2021